Hydroxyethyl starch - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Hydroxyethyl starch (HES) solutions for infusion: suspension of marketing authorisations due to continued use in contraindicated patient populations with increased risk of serious harm

Dissemination date: 30/06/2022

Key facts

• Active substance:
  hydroxyethyl starch
• Regulatory outcome:
  Suspension
• DHPC type:
  Post-authorisation measure
• Dissemination date:
  30/06/2022